Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
14744 | 752 | 31.0 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
14744 | 1 | TOPIRAMATE//TOPIRAMATE TOPAMAX//QUDEXY XR | 752 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TOPIRAMATE | authKW | 7273910 | 63% | 38% | 477 |
2 | TOPIRAMATE TOPAMAX | authKW | 129932 | 1% | 80% | 4 |
3 | QUDEXY XR | authKW | 121812 | 0% | 100% | 3 |
4 | HYPOHIDROSIS | authKW | 92683 | 1% | 21% | 11 |
5 | TOPIRAMATE TOXICITY | authKW | 91358 | 0% | 75% | 3 |
6 | TOPIRAMATE TPM | authKW | 91358 | 0% | 75% | 3 |
7 | CAS 97240 79 4 | authKW | 81208 | 0% | 100% | 2 |
8 | CNS PROJECTS | address | 81208 | 0% | 100% | 2 |
9 | OFICINA INVEST MED | address | 81208 | 0% | 100% | 2 |
10 | OLIGOHIDROSIS | authKW | 81208 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 10507 | 51% | 0% | 385 |
2 | Psychiatry | 2034 | 19% | 0% | 146 |
3 | Pharmacology & Pharmacy | 1153 | 24% | 0% | 184 |
4 | Neurosciences | 575 | 18% | 0% | 136 |
5 | Behavioral Sciences | 281 | 5% | 0% | 36 |
6 | Pediatrics | 177 | 6% | 0% | 47 |
7 | Medical Laboratory Technology | 96 | 2% | 0% | 16 |
8 | Substance Abuse | 94 | 2% | 0% | 14 |
9 | Toxicology | 54 | 3% | 0% | 25 |
10 | Chemistry, Analytical | 26 | 4% | 0% | 31 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CNS PROJECTS | 81208 | 0% | 100% | 2 |
2 | OFICINA INVEST MED | 81208 | 0% | 100% | 2 |
3 | CHILDRENS COMPREHENS EPILEPSY PROGRAM | 78079 | 1% | 38% | 5 |
4 | CORP OFF SCI TECHNOL | 60903 | 0% | 50% | 3 |
5 | CLIN COGNIT NEUROPHARMACOL | 59705 | 1% | 29% | 5 |
6 | BRANCH EXOGENOUSORGAN DISORDERS EPILEPSY | 54138 | 0% | 67% | 2 |
7 | ORPHAN DRUG | 47360 | 1% | 17% | 7 |
8 | ANESTHESIAARNOLD PAIN MANAGEMENT | 40604 | 0% | 100% | 1 |
9 | ANIM BIOL BIOMED PLICAT | 40604 | 0% | 100% | 1 |
10 | ASS OASI MARIA SANTISSIMA | 40604 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSIA | 35316 | 12% | 1% | 88 |
2 | REVIEWS IN CONTEMPORARY PHARMACOTHERAPY | 11396 | 1% | 6% | 5 |
3 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 10424 | 3% | 1% | 25 |
4 | EPILEPSY & BEHAVIOR | 8930 | 4% | 1% | 30 |
5 | ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 8567 | 3% | 1% | 21 |
6 | EPILEPSY RESEARCH | 8192 | 4% | 1% | 28 |
7 | CLINICAL NEUROPHARMACOLOGY | 2424 | 2% | 1% | 12 |
8 | PEDIATRIC NEUROLOGY | 2137 | 2% | 0% | 15 |
9 | REVISTA DE NEUROLOGIA | 1874 | 2% | 0% | 16 |
10 | THERAPEUTIC DRUG MONITORING | 1816 | 2% | 0% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TOPIRAMATE | 7273910 | 63% | 38% | 477 | Search TOPIRAMATE | Search TOPIRAMATE |
2 | TOPIRAMATE TOPAMAX | 129932 | 1% | 80% | 4 | Search TOPIRAMATE+TOPAMAX | Search TOPIRAMATE+TOPAMAX |
3 | QUDEXY XR | 121812 | 0% | 100% | 3 | Search QUDEXY+XR | Search QUDEXY+XR |
4 | HYPOHIDROSIS | 92683 | 1% | 21% | 11 | Search HYPOHIDROSIS | Search HYPOHIDROSIS |
5 | TOPIRAMATE TOXICITY | 91358 | 0% | 75% | 3 | Search TOPIRAMATE+TOXICITY | Search TOPIRAMATE+TOXICITY |
6 | TOPIRAMATE TPM | 91358 | 0% | 75% | 3 | Search TOPIRAMATE+TPM | Search TOPIRAMATE+TPM |
7 | CAS 97240 79 4 | 81208 | 0% | 100% | 2 | Search CAS+97240+79+4 | Search CAS+97240+79+4 |
8 | OLIGOHIDROSIS | 81208 | 0% | 100% | 2 | Search OLIGOHIDROSIS | Search OLIGOHIDROSIS |
9 | OLIGOHYDROSIS | 81208 | 0% | 100% | 2 | Search OLIGOHYDROSIS | Search OLIGOHYDROSIS |
10 | TOPAMAX TOPIRAMAT | 81208 | 0% | 100% | 2 | Search TOPAMAX+TOPIRAMAT | Search TOPAMAX+TOPIRAMAT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHANK, RP , MARYANOFF, BE , (2008) MOLECULAR PHARMACODYNAMICS, CLINICAL THERAPEUTICS, AND PHARMACOKINETICS OF TOPIRAMATE.CNS NEUROSCIENCE & THERAPEUTICS. VOL. 14. ISSUE 2. P. 120-142 | 102 | 46% | 49 |
2 | GUERRINI, R , PARMEGGIANI, L , (2006) TOPIRAMATE AND ITS CLINICAL APPLICATIONS IN EPILEPSY.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 7. ISSUE 6. P. 811-823 | 71 | 70% | 42 |
3 | LATINI, G , VERROTTI, A , MANCO, R , SCARDAPANE, A , DEL VECCHIO, A , CHIARELLI, F , (2008) TOPIRAMATE: ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN EPILEPSY.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 8. ISSUE 1. P. 10-23 | 68 | 65% | 16 |
4 | BEN-MENACHEM, E , SANDER, JW , STEFAN, H , SCHWALEN, S , SCHAUBLE, B , (2008) TOPIRAMATE MONOTHERAPY IN THE TREATMENT OF NEWLY OR RECENTLY DIAGNOSED EPILEPSY.CLINICAL THERAPEUTICS. VOL. 30. ISSUE 7. P. 1180-1195 | 50 | 83% | 19 |
5 | DELL'ORTO, VG , BELOTTI, EA , GOEGGEL-SIMONETTI, B , SIMONETTI, GD , RAMELLI, GP , BIANCHETTI, MG , LAVA, SAG , (2014) METABOLIC DISTURBANCES AND RENAL STONE PROMOTION ON TREATMENT WITH TOPIRAMATE: A SYSTEMATIC REVIEW.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 77. ISSUE 6. P. 958 -964 | 37 | 84% | 11 |
6 | LYSENG-WILLIAMSON, KA , YANG, LPH , (2007) TOPIRAMATE - A REVIEW OF ITS USE IN THE TREATMENT OF EPILEPSY.DRUGS. VOL. 67. ISSUE 15. P. 2231-2256 | 53 | 66% | 49 |
7 | SOMMER, BR , MITCHELL, EL , WROOLIE, TE , (2013) TOPIRAMATE: EFFECTS ON COGNITION IN PATIENTS WITH EPILEPSY, MIGRAINE HEADACHE AND OBESITY.THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. VOL. 6. ISSUE 4. P. 211-227 | 55 | 53% | 21 |
8 | BENTUE-FERRER, D , TRIBUT, O , VERDIER, MC , (2010) THERAPEUTIC DRUG MONITORING OF TOPIRAMATE..THERAPIE. VOL. 65. ISSUE 1. P. 17 -22 | 43 | 78% | 1 |
9 | VERROTTI, A , SCAPARROTTA, A , AGOSTINELLI, S , DI PILLO, S , CHIARELLI, F , GROSSO, S , (2011) TOPIRAMATE-INDUCED WEIGHT LOSS: A REVIEW.EPILEPSY RESEARCH. VOL. 95. ISSUE 3. P. 189-199 | 46 | 49% | 35 |
10 | PINTO, EC , DOLZAN, MD , CABRAL, LM , ARMSTRONG, DW , DE SOUSA, VP , (2015) TOPIRAMATE: A REVIEW OF ANALYTICAL APPROACHES FOR BIOLOGICAL MATRICES.BIOMEDICAL CHROMATOGRAPHY. VOL. 29. ISSUE 10. P. 1461 -1472 | 33 | 63% | 0 |
Classes with closest relation at Level 1 |